Enodia Therapeutics Announces Research Collaboration and License Agreement With Pfizer
Enodia Therapeutics announced a research collaboration and license agreement with Pfizer to develop Sec61-targeting small molecules.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.
Enodia Therapeutics Announces Research Collaboration and License Agreement with Pfizer to Develop Sec61 — Targeting Small Molecules
For best results when printing this announcement, please click on link below: Enodia Therapeutics Announces Research Collaboration and License Agreement with Pfizer to Develop Sec61-Targeting Small Molecules Enodia Therapeutics, a biotechnology company developing novel small-molecule therapies for targeted protein degr